免疫功能低下患者的社区获得性肺炎:来自单一中心的观察性研究,土耳其
Ezgi Yılmaz1, Aysun Benli2, Seniha Başaran2
1Infectious Diseases and Clinical Microbiology, Istanbul Medipol University, Istanbul, Turkey.
对于社区获得性肺炎 (CAP) 的免疫功能低下患者来说,早期治疗反应至关重要. 如果在三天内没有反应,则表明死亡风险很高,突显了管理这些脆弱人群的未满足临床需求.
科学领域:
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
- 临床研究 临床研究
背景情况:
- 免疫功能受损的个体通常被排除在临床试验之外.
- 在这一群体中缺乏社区获得性肺炎 (CAP) 的有效管理策略.
研究的目的:
- 为了确定在免疫受损患者中管理CAP的未满足需求.
- 调查影响该患者群体死亡率的因素.
主要方法:
- 140名 CAP 患者的观察性研究,这些患者有记录的免疫性损害或并发病症.
- 临床评估在呈现时和入院后的第三天.
- 统计分析以确定死亡率的预测因素.
主要成果:
- 整体30天死亡率为17.8%.
- 在Pseudomonas aeruginosa或多微生物感染中观察到更高的死亡率 (p=0.049).
- 呼吸暂停和治疗反应延迟 (在第3天没有反应) 是强烈的死亡率预测因素.
结论:
- 早期治疗反应是免疫功能低下的CAP患者结果的关键预测因素.
- 在三天内没有反应的患者面临极高的死亡率.
- 这凸显了针对免疫功能受损宿主在CAP管理中的重大未满足需求.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
相关概念视频
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
